Pathological paraments | Â |
---|---|
Tumor size, cm | 6.18 ± 3.08 |
Borrmann classification | Â |
 Type-I | 4 (6%) |
 Type-II | 8 (13%) |
 Type-III | 12 (19%) |
 Type-IV | 14 (22%) |
 Unknown | 25 (40%) |
WHO classification | Â |
 Adenocarcinoma | 55 (87%) |
 Others | 7 (11%) |
 Unknown | 1 (2%) |
Signet ring cell carcinoma | Â |
 Yes | 24 (38%) |
 No | 37 (58%) |
 Unknown | 2 (4%) |
Differentiation | Â |
 Poor | 43 (68%) |
 Poor-medium | 12 (19%) |
 Medium | 3 (5%) |
 Unknown | 5 (8%) |
Lauren classification | Â |
 Intestinal type | 12 (19%) |
 Diffuse type | 21 (33%) |
 Mixed type | 11 (18%) |
 Unknown | 19 (30%) |
Nerve invasion | Â |
 Yes | 46 (73%) |
 No | 5 (8%) |
 Unknown | 12 (19%) |
Vascular invasion | Â |
 Yes | 41 (65%) |
 No | 10 (16%) |
 Unknown | 12 (19%) |
T Stage | Â |
 T3 | 7 (11%) |
 T4 | 29 (47%) |
 ypT1a | 2 (3%) |
 ypT2 | 1 (1%) |
 ypT3 | 2 (3%) |
 ypT4 | 14 (22%) |
 Unknown | 8 (13%) |
N Stage | Â |
 N0 | 4 (7%) |
 N1 | 1 (1%) |
 N2 | 11 (13%) |
 N3 | 20 (33%) |
 ypN0 | 5 (8%) |
 ypN1 | 3 (6%) |
 ypN2 | 3 (6%) |
 ypN3 | 7 (11%) |
 Unknown | 9 (15%) |
M Stage | Â |
 0 | 40 (65%) |
 1 | 20 (32%) |
 Unknown | 3 (6%) |
TNM Stage | Â |
 Stage I | 3 (6%) |
 Stage II | 2 (3%) |
 Stage III | 37 (58%) |
 Stage IV | 19 (30%) |
 Unknown | 2 (3%) |
Detected lymph nodes number | 36 ± 17.66 |
Positive lymph nodes number | 11.89 ± 14.99 |
AFP | Â |
 Positive | 0 (0%) |
 Negative | 32 (51%) |
 Unknown | 31 (49%) |
GPC3 | Â |
 Positive | 2 (3%) |
 Negative | 28 (45%) |
 Unknown | 33 (52%) |
SALL4 | Â |
 Positive | 5 (8%) |
 Negative | 26 (41%) |
 Unknown | 32 (51%) |
Her2 | Â |
 Negative | 29 (46%) |
 +  | 14 (22%) |
 2 +  | 2 (3%) |
 3 +  | 1 (2%) |
 Unknown | 17 (27%) |